Table 2:
Baseline characteristics.
| Total | Unique cases | |
|---|---|---|
| (N=1045) | (N=501) | |
| Male (%) | 571 (54.6) | 267 (53.3) |
| Age (SD) | 60.3 (15.9) | 61.6 (15.7) |
| BMI (SD) | 26.8 (5.6) | 27.0 (5.1) |
| BMI (kg/m2) | (n=998) | |
| <20 | 8 (0.8) | 4 (0.8) |
| 20-25 | 348 (33.3) | 168 (33.5) |
| 25-30 | 411 (39.3) | 172 (34.3) |
| 30-40 | 214 (20.5) | 104 (20.8) |
| >40 | 17 (1.6) | 9 (1.8) |
| Etiology (%) | ||
| ANCA-associated vasculitis | - | 119 (23.8) |
| Nephrosclerosis | - | 76 (15.2) |
| Diabetes nephropathy | - | 35 (7.0) |
| ADPKD | - | 21 (4.2) |
| IgA nephropathy | - | 21 (4.2) |
| Urologic disease | - | 17 (3.4) |
| Miscellaneous | - | 289 (57.7) |
| KDIGO stage (%) | ||
| 1 | 119 (11.4) | 42 (8.4) |
| 2 | 262 (25.1) | 93 (18.6) |
| 3a | 187 (17.9) | 66 (13.2) |
| 3b | 157 (15.0) | 72 (14.4) |
| 4 | 225 (21.5) | 155 (30.9) |
| 5 | 95 (9.1) | 73 (14.6) |
| Systolic blood pressure (SD) | 125.3 (16.0) | 127.0 (16.2) |
| Diabetes Mellitus (%) | 228 (21.8) | |
| Type 1 (%) | 7 (0.7) | |
| Type 2 (%) | 221 (21.1) | |
| Insulin dependent (%) | 80 (7.6) | |
| Protein intake (g/kg/day) | (n=833) | |
| < 0.8 | 240 (23.0) | |
| 0.8-1.2 | 444 (42.5) | |
| >1.2 | 149 (14.3) |